<DOC>
	<DOCNO>NCT01433120</DOCNO>
	<brief_summary>Studies human gut microbiome suggest treatment prevention aim obese microbiome could influence development obesity-associated metabolic disturbance . The objective project explore dietary intervention 60 obese woman probiotic Lactobacillus paracasei ssp paracasei F19 flax seed fibres target gut microbiome , reduce insulin resistance , low-grade inflammation dyslipidaemia , explore interaction human genome gut microbiome . The study base follow hypothesis : - Treatment probiotic Lactobacillus paracasei ssp paracasei F19 flax seed fibres low metabolic risk profile intervention group compare placebo . - The effect metabolic risk marker correlate change gut microbiota ( measured faeces ) . After completion dietary intervention , participant offer 10-week weight reduction program . Those participate weight-loss program invite optional follow-up visit connection last visit clinical dietician , purpose explore effect weight loss gut microbiota obesity-associated metabolic disturbance .</brief_summary>
	<brief_title>Targeting Gut Microbiome Investigate Pathways Progression From Obesity Metabolic Diseases At-risk Population .</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<criteria>Postmenopausal BMI 3045 kg/m2 Waist circumference &gt; 80 cm High leukocyte count Medicallytreated Type 2 diabetes dyslipidaemia Use antibiotic last 3 month Use pro prebiotic supplement last 6 week Illnesses relate gastrointestinal tract History psychiatric disease ( incl . depression ) Liver disease Alcohol abuse</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Microbiota</keyword>
	<keyword>Probiotic</keyword>
	<keyword>Prebiotic</keyword>
</DOC>